🔎 Trials Near Me

Utama › Glioma › Florida

Kajian klinikal Glioma di Florida

23 kajian untuk Glioma sedang mencari peserta di lokasi di Florida.

Bandar di Florida

Teks kajian rasmi (Bahasa Inggeris)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  • Golisano Children's Hospital of Southwest Florida, Fort Myers
  • Nemours Children's Clinic-Jacksonville, Jacksonville
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
  • dan 4 lagi
Mengambil pesertaFasa 1/2
12 Months – 21 Years · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05099003

Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

  • Mayo Clinic in Florida, Jacksonville
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05030298

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Miami Cancer Institute, Miami
  • Moffitt Cancer Center, Tampa
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07326566

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

  • Nicklaus Children's Hospital, Miami
Mengambil pesertaFasa 2
12 Months – 39 Years · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

  • University of Miami, Miami
Mengambil pesertaKajian pemerhatian
12 Months – 39 Years · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

  • University of Miami Hospital and Clinics, Miami
Mengambil pesertaFasa 2
Umur 12 hingga 39 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • University of Florida Health, Gainesville
  • Mayo Clinic - Florida, Jacksonville
  • University of Miami Health, Miami
  • dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Nicklaus Children's Hospital, Miami
Mengambil pesertaFasa 2
Umur 3 hingga 39 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05096481

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

  • University of Florida, Gainesville
Mengambil pesertaFasa 1
Umur 1 hingga 25 · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT04485559

A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial

  • Mayo Clinic in Florida, Jacksonville
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT07074756

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

  • Moffitt Cancer Center, Tampa
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jul 2026 · NCT07464925

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • University of Miami Hospital and Clinics, Miami
Mengambil pesertaFasa 2
Umur 8 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05503797

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

  • BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jul 2026 · NCT05188508

A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

  • UF Health, Gainesville
Mengambil pesertaFasa 1
Umur 4 ke atas · Semua jantina · Dikemas kini 25 Jun 2026 · NCT04573140

STARLITE for Unresectable High-Grade Gliomas

  • University of Miami, Miami
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Jun 2026 · NCT06428045

PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial

  • Lynn Cancer Institute at Baptist Health, Inc., Boca Raton
  • Miami Cancer Institute at Baptist Health, Inc., Miami
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Jun 2026 · NCT06397560

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

  • University of Miami Hospital, Miami
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Mei 2026 · NCT06264388

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

  • Moffitt Cancer Center, Tampa
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Apr 2026 · NCT06326411

Non-invasive Glioma Characterization Through Molecular Imaging

  • University of Miami, Miami
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Apr 2026 · NCT03684109

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • Mayo Clinic Jacksonville, Jacksonville
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Apr 2026 · NCT06810544

Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

  • Mayo Clinic in Florida, Jacksonville
Mengambil pesertaFasa 1
Umur 18 hingga 75 · Semua jantina · Dikemas kini 24 Mac 2026 · NCT06482905

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

  • University of Miami, Miami
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Mac 2026 · NCT06504381

Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors

  • University of Miami Hospital, Miami
Mengambil pesertaFasa 1/2
Sehingga umur 18 · Semua jantina · Dikemas kini 20 Nov 2025 · NCT04299191

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.